Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

High-dose ifosfamide standard of care for recurrent and primary refractory ewing sarcoma

Dr Martin McCabe - University of Manchester, Manchester, England
High-dose ifosfamide standard of care for recurrent and primary refractory ewing sarcoma ( Dr Martin McCabe - University of Manchester, Manchester, England )
5 Jun 2022

(RVd) ± , stem cell transplantation and R maintenance shows significance for newly diagnosed myeloma patients

Dr Paul Richardson- Dana Farber Cancer Institute, Boston, USA
(RVd) ± , stem cell transplantation and R maintenance shows significance for newly diagnosed myeloma patients ( Dr Paul Richardson- Dana Farber Cancer Institute, Boston, USA )
5 Jun 2022

Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM: Phase 3 DETERMINATION trial

Dr Paul Richardson - Dana Farber Cancer Institute, Boston, USA
Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM: Phase 3 DETERMINATION trial ( Dr Paul Richardson - Dana Farber Cancer Institute, Boston, USA )
5 Jun 2022

Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient locally advanced rectal cancer

Dr Andrea Cercek - Memorial Sloan Kettering Cancer Centre, Manhattan, New York
Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient locally advanced rectal cancer ( Dr Andrea Cercek - Memorial Sloan Kettering Cancer Centre, Manhattan, New York )
5 Jun 2022

Avasopasem produces significant improvement of severe oral mucositis in head and neck patients

Dr Carryn Anderson - University of Texas Medical Branch, Texas, USA
Avasopasem produces significant improvement of severe oral mucositis in head and neck patients ( Dr Carryn Anderson - University of Texas Medical Branch, Texas, USA )
4 Jun 2022

Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer

Dr Jeanne Tie - The Peter MacCallum Cancer Centre, Melbourne, Australia
Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer ( Dr Jeanne Tie - The Peter MacCallum Cancer Centre, Melbourne, Australia )
4 Jun 2022

Everolimus after surgery can improve outcomes in those with high-risk kidney cancer

Dr Christopher Ryan - OHSU Knight Cancer Institute, Portland, USA
Everolimus after surgery can improve outcomes in those with high-risk kidney cancer ( Dr Christopher Ryan - OHSU Knight Cancer Institute, Portland, USA )
4 Jun 2022

Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma

Dr Michael Wang - MD Anderson Cancer Center, Houston, USA
Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma ( Dr Michael Wang - MD Anderson Cancer Center, Houston, USA )
4 Jun 2022

N-803-BCG combination shows promising results in BCG-unresponsive NMIBC

Dr Karim Chamie - UCLA School of Medicine, Los Angeles, USA
N-803-BCG combination shows promising results in BCG-unresponsive NMIBC ( Dr Karim Chamie - UCLA School of Medicine, Los Angeles, USA )
4 Jun 2022

Sacituzumab goviteca provides clinically meaningful PFS benefit for hormone receptor HR+/HER2‐ advanced breast cancer patients

Dr Hope Rugo - University of California San Francisco, San Francisco, USA
Sacituzumab goviteca provides clinically meaningful PFS benefit for hormone receptor HR+/HER2‐ advanced breast cancer patients ( Dr Hope Rugo - University of California San Francisco, San Francisco, USA )
4 Jun 2022

Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer

Dr Jane Lowe Meisel - Winship Cancer Institute of Emory University, Georgia, USA
Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer ( Dr Jane Lowe Meisel - Winship Cancer Institute of Emory University, Georgia, USA )
4 Jun 2022

Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer

Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia
Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer ( Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia )
4 Jun 2022